These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23681400)

  • 1. Severity and management of drug-drug interactions in acute geriatric patients.
    Lea M; Rognan SE; Koristovic R; Wyller TB; Molden E
    Drugs Aging; 2013 Sep; 30(9):721-7. PubMed ID: 23681400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of a clinical decision support system and of clinical pharmacists in preventing drug-drug interactions on a geriatric ward.
    Cornu P; Steurbaut S; Soštarić S; Mrhar A; Dupont AG
    Int J Clin Pharm; 2014 Jun; 36(3):519-25. PubMed ID: 24566821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck(®)).
    Ghibelli S; Marengoni A; Djade CD; Nobili A; Tettamanti M; Franchi C; Caccia S; Giovarruscio F; Remuzzi A; Pasina L
    Drugs Aging; 2013 Oct; 30(10):821-8. PubMed ID: 23943248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-drug interactions in a cohort of hospitalized elderly patients.
    Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance.
    Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C
    J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant drug-drug interactions among elderly people with dementia.
    Sönnerstam E; Sjölander M; Lövheim H; Gustafsson M
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1351-1360. PubMed ID: 29967921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting.
    Hasan SS; Lim KN; Anwar M; Sathvik BS; Ahmadi K; Yuan AW; Kamarunnesa MA
    Singapore Med J; 2012 Aug; 53(8):526-31. PubMed ID: 22941130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions in dying patients: a retrospective analysis of hospice inpatients in Germany.
    Frechen S; Zoeller A; Ruberg K; Voltz R; Gaertner J
    Drug Saf; 2012 Sep; 35(9):745-58. PubMed ID: 22809376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
    Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
    Guastaldi RB; Reis AM; Figueras A; Secoli SR
    Int J Clin Pharm; 2011 Dec; 33(6):1002-9. PubMed ID: 21993569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
    Fettah H; Moutaouakkil Y; Sefrioui MR; Moukafih B; Bousliman Y; Bennana A; Lamsaouri J; Makram S; Cherrah Y
    Pan Afr Med J; 2018; 29():225. PubMed ID: 30100979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao.
    Lao CK; Ho SC; Chan KK; Tou CF; Tong HH; Chan A
    Int J Clin Pharm; 2013 Oct; 35(5):805-12. PubMed ID: 23812679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.
    Tulner LR; Frankfort SV; Gijsen GJ; van Campen JP; Koks CH; Beijnen JH
    Drugs Aging; 2008; 25(4):343-55. PubMed ID: 18361544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
    Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
    PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.